Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5.
about
Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related Siglecs in primatesColloquium paper: uniquely human evolution of sialic acid genetics and biologyA maternal vaccine against group B Streptococcus: past, present, and futureBacterial immune evasion through manipulation of host inhibitory immune signalingFuture perspective on host-pathogen interactions during bacterial biofilm formation within the nasopharynxSiglecs and immune regulationMicrobial manipulation of receptor crosstalk in innate immunitySoluble Siglec-5 associates to PSGL-1 and displays anti-inflammatory activity.Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivoSiglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus.Ubiquitous sialometabolism present among oral fusobacteriaThe interplay between Siglecs and sialylated pathogensEngagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancerEngagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes.Multivalent ligands for siglecs.Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs.Relative over-reactivity of human versus chimpanzee lymphocytes: implications for the human diseases associated with immune activation.Early murine T-lymphocyte activation is accompanied by a switch from N-Glycolyl- to N-acetyl-neuraminic acid and generation of ligands for siglec-ELeukocyte inflammatory responses provoked by pneumococcal sialidase.Specific inactivation of two immunomodulatory SIGLEC genes during human evolution.Evolution of siglec-11 and siglec-16 genes in homininsImmunomodulatory activity of extracellular Hsp70 mediated via paired receptors Siglec-5 and Siglec-14.The Group B Streptococcus-Secreted Protein CIP Interacts with C4, Preventing C3b Deposition via the Lectin and Classical Complement PathwaysRefolded recombinant Siglec5 for NMR investigation of complex carbohydrate bindingGlycobiology of cell death: when glycans and lectins govern cell fate.Sialic acids siglec interaction: a unique strategy to circumvent innate immune response by pathogens.Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?Immune inhibitory receptors: essential regulators of phagocyte function.CD33-related siglecs as potential modulators of inflammatory responses.How do pathogens drive the evolution of paired receptors?Siglec functions of microglia.Associations of genetic polymorphisms of Siglecs with human diseases.Subterfuge and sabotage: evasion of host innate defenses by invasive gram-positive bacterial pathogens.Pneumococci in biofilms are non-invasive: implications on nasopharyngeal colonization.Regulation of neutrophil functions through inhibitory receptors: an emerging paradigm in health and disease.Sialic acids in cancer biology and immunity.Innate immunity against molecular mimicry: Examining galectin-mediated antimicrobial activity.Human Siglec-5 inhibitory receptor and immunoglobulin A (IgA) have separate binding sites in streptococcal beta protein.Studies on the Detection, Expression, Glycosylation, Dimerization, and Ligand Binding Properties of Mouse Siglec-E.Biochemical, Cellular, Physiological, and Pathological Consequences of Human Loss of N-Glycolylneuraminic Acid.
P2860
Q24603469-C5EE2AC6-58DB-4C06-B499-5D01F9D637FEQ24634579-1D858D4B-1097-4171-8796-13F889DBE753Q26822039-0C2F2FB7-D239-4C73-919E-8F0D0ACBD2C6Q26849421-92EA0499-5A62-42FB-B398-DBEDFCEE4F1FQ26863174-9989898C-CB40-4082-B706-D50CEFDB8CB5Q26992091-4309D6B2-6145-4073-B86A-C6F959C074FAQ30499616-0E005AEC-0457-45CD-B0DD-5B32D5C8FCBCQ30829904-23C4B603-DE9A-4B46-8928-7B781FC0B0E3Q33615157-60E944F7-A6D2-4D9C-A5BC-4096BD7B6BD4Q33702945-C81FCDB8-EDCC-4606-A91E-7D5876ABA185Q33712609-612147D0-75EE-4C60-AD49-37523642FEC1Q34208951-F90197E8-C434-4D1B-9F57-FA34D698FA65Q34314456-CB4C03BB-C7F7-4607-AD88-F3C48915421CQ34430165-635A5E70-EE25-4F4B-92BD-995EB554B5C3Q34449574-F75D6DEA-9F1B-4D18-9063-B937AF94CA0AQ34580364-4D931964-BC04-43A0-BD50-76F02A1BCB1FQ34903504-48024771-51A2-499C-9DC4-B50404F06D3BQ35266949-099C5B97-B40A-48F8-B450-83E8C57E9D97Q35652328-5FF0A1F5-3594-4634-A716-41F815824358Q36056595-B43AEAD4-8981-4AE0-BDE7-6B403C0774A4Q36126768-2B673980-595C-4C4A-A82F-8FD12ABC27B6Q36380685-15E82FFF-2849-409A-BBF1-7854F6145276Q36382263-54A78BD2-1291-4AF9-9C69-68956241A4C9Q36672921-CD808847-FB75-461E-A631-3808DE2716D5Q36994801-6E365941-70E1-41D8-B932-620EEF6B8DCAQ37592363-F932EBF2-F5E1-4D61-AF45-4FB45EE0BC31Q37808728-5B65C838-2D87-4564-A5D2-12AFE34F175BQ37839870-2520E8BE-4D32-436F-ADA9-B14B10057225Q37986851-01CC78B0-14B9-4BF0-9870-E6B42647D78CQ38070978-28F76B0D-E274-4A5C-9A82-C4DB49CA48FDQ38212200-24AB8CC1-8857-4D11-8C99-3F7B23CC21E3Q38212860-9B126298-532D-4B4D-90EF-88F86C2A69EBQ38227102-DAEE19FC-9CB4-4142-B7AE-B4D967ABF53FQ38270198-CE0EC2D9-DA24-4C8D-883C-F3C9703D6CB1Q38377860-E261C14C-0126-4CF2-A431-A6D304C9C648Q38620799-3FBA9FDF-8641-465C-AFBA-CDAB4A6D4B3FQ38635983-9FA077B5-5159-4100-BAC6-6EC08265ABC7Q38674244-AB1F61E4-A131-421A-9A8E-1B093B70F38CQ39128543-0EB5F9A3-F386-4E9D-9F50-218418565E22Q39250748-C4048001-AF90-42F1-B3B7-76BE982DCC52
P2860
Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Group B Streptococcus suppress ...... engagement of human Siglec-5.
@en
Group B Streptococcus suppress ...... engagement of human Siglec-5.
@nl
type
label
Group B Streptococcus suppress ...... engagement of human Siglec-5.
@en
Group B Streptococcus suppress ...... engagement of human Siglec-5.
@nl
prefLabel
Group B Streptococcus suppress ...... engagement of human Siglec-5.
@en
Group B Streptococcus suppress ...... engagement of human Siglec-5.
@nl
P2093
P2860
P356
P1476
Group B Streptococcus suppress ...... engagement of human Siglec-5.
@en
P2093
Aaron F Carlin
Ajit Varki
Charles C King
Gunnar Lindahl
Nancy Hurtado-Ziola
Thomas Areschoug
Yung-Chi Chang
P2860
P304
P356
10.1084/JEM.20090691
P407
P50
P577
2009-07-13T00:00:00Z